Food and Drug Administration (FDA) has approved the use of L-carnitine as a complementary treatment for individuals with serious kidney disease who are undergoing hemodialysis, albeit, delivered intravenously
The research has been published in The BMJ
Your unstimulated baseline is not zero, which compresses the measurable agonist window and makes an inverse agonist a more informative control than vehicle alone
Side Effects and Safety Across all published research, ipamorelin has demonstrated a favorable safety profile: No significant cortisol or prolactin elevation at therapeutic doses No meaningful appetite stimulation Mild and transient side effects including headache, flushing, and injection site irritation No serious adverse events reported in published clinical trials at standard doses The main limitation is the absence of long-term safety data from large-scale human studies
Naoi M, Maruyama W, Akao Y, Yi H
If you want a broader overview of its role in the body, What is Glutathione and Why It Matters for Our Health is a helpful next read